Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 11:05:15 GMT 2023
by
admin
on
Sat Dec 16 11:05:15 GMT 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
BI009E452R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
437414
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
||
|
WHO-ATC |
V03AB38
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000166815
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
PRIMARY | |||
|
BI009E452R
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
PRIMARY | |||
|
BC-65
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
PRIMARY | |||
|
2045114
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
PRIMARY | |||
|
BI009E452R
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
PRIMARY | |||
|
C171753
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
PRIMARY | |||
|
CHEMBL3301583
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
PRIMARY | |||
|
DB14562
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
PRIMARY | |||
|
5336
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
PRIMARY | |||
|
SUB181082
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
PRIMARY | |||
|
2045125
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
ALTERNATIVE | |||
|
9883
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
PRIMARY | |||
|
Andexanet alfa
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
PRIMARY | |||
|
1262449-58-0
Created by
admin on Sat Dec 16 11:05:15 GMT 2023 , Edited by admin on Sat Dec 16 11:05:15 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_7 | 1_12 |
1_27 | 1_43 |
1_108 | 2_98 |
1_156 | 1_170 |
1_181 | 1_209 |
2_16 | 2_27 |
2_21 | 2_36 |
2_38 | 2_47 |
2_55 | 2_66 |
2_62 | 2_75 |
2_77 | 2_90 |
Glycosylation Link Type | Site |
---|---|
O | 1_82 |
O | 1_249 |
O | 2_56 |
O | 2_72 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
PRT064445 has high affinity for small molecule fXa inhibitors
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|